Search for: "Eli, Inc."
Results 41 - 60
of 1,001
Sorted by Relevance
|
Sort by Date
24 Jan 2011, 12:31 pm
On January 20, 2011, Eli Lilly and Company of Indianapolis, Indiana (“Lilly”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
4 Jun 2009, 9:56 pm
Eli Lilly), Judge Rader's decision confirms that the written description requirement is particularly relevant to the essential interference question of inventive priority. [read post]
6 Feb 2020, 12:43 pm
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company (“Lilly”) of Indianapolis, Indiana, filed suit in the Southern District of Indiana seeking a declaratory judgment that Lilly did not misappropriate any trade secrets of Defendant, SensorRx, Inc. [read post]
11 Oct 2012, 1:00 am
Teva Parenteral Medicines, Inc., the Federal Circuit affirmed the district court’s decision that Eli Lilly’s patent to pemetrexed is not invalid for obviousness-type double patenting. [read post]
25 Oct 2017, 6:55 am
Other petitioners joined in the case are Apotex, Inc, Teva Pharmaceuticals USA, Fresenius Kabi USA, and Wockhardt Bio AG. [read post]
9 Dec 2009, 9:24 pm
Noonan -- Oral argument in Ariad Pharmaceuticals, Inc. v. [read post]
5 Jul 2018, 7:20 am
’Additionally, in Pfizer Inc. v. [read post]
5 Jul 2018, 7:20 am
’Additionally, in Pfizer Inc. v. [read post]
8 Feb 2016, 10:40 pm
Reddy's Laboratories, Inc. of Princeton, New Jersey is acting on behalf of Dr. [read post]
24 Aug 2012, 2:57 pm
Court of Appeals for the Federal Circuit on Friday affirmed a lower court's ruling that Eli Lilly & Co.'s patent for the chemotherapy drug pemetrexed, marketed under the name Alimta, is valid, overruling a challenge from generic pharmaceutical makers Teva Parenteral Medicines Inc., Barr Laboratories Inc. and APP Pharmaceuticals Inc. [read post]
29 Dec 2020, 9:15 am
In Eli Lilly & Co. v. [read post]
7 Nov 2016, 1:34 pm
Apotex Inc., et al. [read post]
27 Nov 2013, 6:00 am
Indianapolis, Indiana - Eli Lilly and Company of Indianapolis, Indiana; Eli Lilly Export S.A. of Geneva, Switzerland (collectively, "Lilly"); and Acrux DDS Pty Ltd. of West Melbourne, Australia have filed a patent infringement lawsuit in the Southern District of Indiana alleging that Actavis, Inc. and Actavis Pharma, Inc., both of Parsippany, New Jersey, and Watson Laboratories, Inc. of Corona, California infringed Patent Nos. 6,299,900 - Dermal… [read post]
25 Apr 2014, 8:17 am
Inc. [read post]
16 Aug 2015, 9:03 pm
Lupin Pharmaceuticals, Inc. et al. 1:15-cv-01047; filed July 6, 2015 in the Southern District of Indiana • Plaintiffs: Eli Lilly and Company; Eli Lilly Export S.A.; Acrux DDS Pty Ltd. [read post]
3 Mar 2013, 8:43 pm
Eli Lilly and Company et al. v. [read post]
17 Mar 2014, 9:59 pm
Eli Lilly and Company et al. v. [read post]
28 Sep 2007, 8:07 am
Emisphere Techs., Inc., No. 03-cv-1504-DFH (S.D. [read post]
15 Jan 2009, 6:39 pm
While Zyprexa has been subject of lawsuits, other drug makers such as Cephalon Inc. [read post]
19 Jul 2011, 1:35 am
In Human Genome Sciences Inc v Eli Lilly and Company [2010] EWCA Civ 33, all of these questions had to be considered before evaluating the validity of a patent owned by Human Genome Sciences (“HGS”). [read post]
